trending Market Intelligence /marketintelligence/en/news-insights/trending/4bxzm0EdnFHYmGK7NSg6zA2 content esgSubNav
In This List

China Biologic to acquire 80% stake in PW Medtech unit

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


China Biologic to acquire 80% stake in PW Medtech unit

China Biologic Products Holdings Inc. said it will acquire PW Medtech Group Ltd.'s 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co. Ltd.

China Biologic will issue 5,521,000 ordinary shares to PW Medtech in return for the equity in Tianxinfu. As a result, PWM will end up owning a 16.66% share in China Biologic.

The transaction is expected to close this year.

PW Medtech recently sold a 20% stake in Tianxinfu to Xinyu Yongshuo Management and Consulting LLP and was considering a spinoff and separate listing of the entity on the Shenzhen or Shanghai stock exchanges.